328 related articles for article (PubMed ID: 24315224)
1. [Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)].
Raffin D; Delaplace M; Roussel A; Estève E
Ann Dermatol Venereol; 2013 Dec; 140(12):784-7. PubMed ID: 24315224
[TBL] [Abstract][Full Text] [Related]
2. A case of anti-laminin γ1 (p200) pemphigoid developed after dipeptidyl peptidase-4 inhibitor administration.
Nakatani K; Noborio R; Nomura Y; Ueki Y; Kiyohara T; Hashimoto T
J Dermatol; 2024 Jun; 51(6):869-872. PubMed ID: 38214494
[TBL] [Abstract][Full Text] [Related]
3. [Anti-p200 pemphigoid: clinical, diagnostic and therapeutic aspects].
Drerup KA; Wehkamp U
Hautarzt; 2020 Feb; 71(2):130-133. PubMed ID: 31501972
[TBL] [Abstract][Full Text] [Related]
4. Symmetrical Skin Lesions on the Gluteal Region in a Patient with Anti-Laminin-332 Mucous Membrane Pemphigoid.
Maki N; Demitsu T; Nagato H; Okada O; Yoneda K; Hashimoto T; Hasunuma N; Osada I; Manabe M
Acta Dermatovenerol Croat; 2021 Jul; 29(2):105-107. PubMed ID: 34477077
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of immunofluorescence overlay antigen mapping in the identification of autoantigen in anti-p200 pemphigoid.
Kitayama S; Makino T; Hayashi M; Mizawa M; Ishii N; Hashimoto T; Shimizu T
J Dermatol; 2023 Sep; 50(9):1194-1198. PubMed ID: 37082790
[TBL] [Abstract][Full Text] [Related]
6. Anti-p200 Pemphigoid: A Systematic Review.
Kridin K; Ahmed AR
Front Immunol; 2019; 10():2466. PubMed ID: 31695695
[TBL] [Abstract][Full Text] [Related]
7. Autoreactive Peripheral Blood T Helper Cell Responses in Bullous Pemphigoid and Elderly Patients With Pruritic Disorders.
Didona D; Scarsella L; Fehresti M; Solimani F; Juratli HA; Göbel M; Mühlenbein S; Holiangu L; Pieper J; Korff V; Schmidt T; Sitaru C; Eming R; Hertl M; Pollmann R
Front Immunol; 2021; 12():569287. PubMed ID: 33841390
[TBL] [Abstract][Full Text] [Related]
8. Rapid Disease Control in First-Line Therapy-Resistant Mucous Membrane Pemphigoid and Bullous Pemphigoid with Omalizumab as Add-On Therapy: A Case Series Of 13 Patients.
Alexandre M; Bohelay G; Gille T; Le Roux-Villet C; Soued I; Morin F; Caux F; Grootenboer-Mignot S; Prost-Squarcioni C
Front Immunol; 2022; 13():874108. PubMed ID: 35514989
[TBL] [Abstract][Full Text] [Related]
9. Case Report: Mucous Membrane Pemphigoid With IgG and IgA Anti-Laminin γ1 Antibodies and IgA Anti-Laminin α5 Antibodies.
Kuang W; Qian H; Zhang Q; Li W; Hashimoto T; Zeng X; Li X
Front Immunol; 2022; 13():903174. PubMed ID: 35720393
[TBL] [Abstract][Full Text] [Related]
10. Autoantibody Detection for Diagnosis in Direct Immunofluorescence-Negative Mucous Membrane Pemphigoid: Ocular and Other Sites Compared.
Dart J; Setterfield J; Groves RW; Mee JB; Diercks GFH; Pas HH; Minassian D;
Ophthalmology; 2021 Mar; 128(3):372-382. PubMed ID: 32745569
[TBL] [Abstract][Full Text] [Related]
11. A Case of Possible Concurrence of Dermatitis Herpetiformis and Linear Immunoglobulin A / Immunoglobulin G Bullous Dermatosis.
Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Sawamura D
Acta Dermatovenerol Croat; 2021 Jul; 29(2):116-117. PubMed ID: 34477081
[TBL] [Abstract][Full Text] [Related]
12. Refractory Pemphigoid with Autoantibodies to Both BP230 and Laminin gamma1.
Ashida H; Hamada T; Hosokawa Y; Hashimoto T; Nishie W; Ishii N; Nakama T; Kanno T; Ikeda M
Acta Derm Venereol; 2019 Nov; 99(12):1172-1173. PubMed ID: 31449311
[No Abstract] [Full Text] [Related]
13. [Pemphigoid diseases in older adults].
Moderegger EL; Schmitz MJ; Ludwig RJ; Sadik CD; Schmidt E
Dermatologie (Heidelb); 2023 Sep; 74(9):687-695. PubMed ID: 37594515
[TBL] [Abstract][Full Text] [Related]
14. Refractory bullous pemphigoid with IgE anti-BP230 and IgG anti-p200 antibodies successfully treated with omalizumab.
Sarrazin M; Jouen F; Duvert-Lehembre S
Ann Dermatol Venereol; 2021 Mar; 148(1):60-62. PubMed ID: 33478824
[No Abstract] [Full Text] [Related]
15. Laminin β4 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoid.
Goletz S; Pigors M; Lari TR; Hammers CM; Wang Y; Emtenani S; Aumailley M; Holtsche MM; Stang FH; Weyers I; König IR; Has C; Radzimski C; Komorowski L; Zillikens D; Schmidt E
J Am Acad Dermatol; 2024 Apr; 90(4):790-797. PubMed ID: 37992812
[TBL] [Abstract][Full Text] [Related]
16. Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients.
Gaudin O; Seta V; Alexandre M; Bohelay G; Aucouturier F; Mignot-Grootenboer S; Ingen-Housz-Oro S; Bernardeschi C; Schneider P; Mellottee B; Caux F; Prost-Squarcioni C
Front Immunol; 2018; 9():1030. PubMed ID: 29881377
[TBL] [Abstract][Full Text] [Related]
17. The Second Study of Clinical and Immunological Findings in Anti-laminin 332-Type Mucous Membrane Pemphigoid Examined at Kurume University-Diagnosis Criteria Suggested by Summary of 133 Cases.
Qian H; Natsuaki Y; Koga H; Kawakami T; Tateishi C; Tsuruta D; Ishii N; Li X; Hashimoto T
Front Immunol; 2021; 12():771766. PubMed ID: 34899722
[TBL] [Abstract][Full Text] [Related]
18. Utility of the pattern-based approach using BIOCHIP-indirect immunofluorescence in the evaluation of subepidermal bullous disorders.
Venkataswamy C; Vinayagam N; Shanmugasundaram S; Rai R
J Cutan Pathol; 2023 Mar; 50(3):259-265. PubMed ID: 36444506
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of Anti-p200 Pemphigoid and Psoriasis: A Systematic Review.
Xie YH; Wang SH; Li SZ; Zuo YG
Front Immunol; 2022; 13():839094. PubMed ID: 35317170
[TBL] [Abstract][Full Text] [Related]
20. Case of pemphigoid with immunoglobulin G antibodies to BP180 C-terminal domain and laminin-γ1 (p200) developed after pneumococcal vaccination.
Maki N; Hashimoto T; Yamada T; Ishii N; Tsuruta D; Demitsu T
J Dermatol; 2021 Jan; 48(1):101-105. PubMed ID: 32974956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
